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The urokinase plasminogen activator receptor (uPAR) is
expressed at the cell surface of inflammatory cells and plays
an important role in neutrophil migration. To investigate the
in vivo role of uPAR during urinary tract infection, acute
pyelonephritis was induced in uPAR/ and wild-type (WT)
mice by intravesical inoculation with 1 109 colony-forming
units (CFU) of uropathogenic Escherichia coli. Mice were
killed after 24 and 48 h, after which bacterial outgrowth
and cytokine levels in kidney homogenates were
determined. Influx of neutrophils was quantified by
myeloperoxidase-enzyme-linked immunosorbent assay.
uPAR/ kidneys had significantly higher numbers of E. coli
CFU, accompanied by higher levels of interleukin-1b (IL-1b),
IL-6, keratinocyte-derived chemokine (KC), macrophage
inflammatory protein-2 (MIP-2), and tumor necrosis factor-a
(TNF-a). However, the number of infiltrating neutrophils was
similar in uPAR/ and WT mice at both time points,
suggesting that uPAR/ neutrophils have a lower ability
to eliminate E. coli. To further investigate this, neutrophil
oxidative burst and phagocytosis was measured. The
generation of reactive oxygen species upon stimulation with
E. coli was not diminished in uPAR/ neutrophils compared
with WT. Interestingly, uPAR/ neutrophils displayed
significantly impaired phagocytosis of E. coli organisms
compared with WT neutrophils. We conclude that uPAR is
crucially involved in host defense through phagocytosis
during E. coli induced acute pyelonephritis.
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Urinary tract infections (UTIs), most frequently caused by
Gram-negative Escherichia coli, are among the most common
bacterial infections, affecting approximately 50% of women
at one point in their lifetime.1 Recurrent episodes of UTIs
afflict about 10% of women worldwide.1 In addition, UTIs
form a considerable pediatric problem, as 8% of girls and
2% of boys under the age of 7 years develop acute pyelo-
nephritis.2 The most important complication of acute
pyelonephritis is renal fibrosis, which is responsible for up
to 24% of children that develop end-stage renal failure.3
Course and outcome of UTIs depend largely on the
balance between bacterial virulence factors and host defense
mechanisms. Virulence factors most strongly associated with
E. coli uropathogenicity include type 1 fimbriae, P fimbriae,
hemolysin, and aerobactin. Type 1 fimbriae are adhesins that
facilitate adherence of E. coli to glycoproteins on the
urothelium, whereas P fimbriae bind to glycolipids that are
expressed by host cells in the kidney. After adhesion has been
achieved, hemolysin facilitates tissue invasion by E. coli and
lysis of host leukocytes, whereas aerobactin is a siderophore
that ensures bacterial metabolism in low-iron environments
such as urine and serum.4
Apart from regular bladder voiding and several urine
components that can act as anti-adherence factors, important
host defense mechanisms against acute pyelonephritis
include antimicrobial peptides such as b-defensin 1, which
is expressed by tubular epithelial cells and has been reported
to be protective against UTIs.5 Recently, so-called danger
signal receptors, most notably Toll-like receptor 4 have been
implicated in the defense against E.coli-mediated UTIs as
well.6,7 In the next phase of host response, complement
activation and rapid production of pro-inflammatory
cytokines and chemokines result in recruitment of neutro-
phils that phagocytose and eliminate E. coli organisms.8
The urokinase plasminogen activator receptor (uPAR,
CD87) has been recognized as an important participant in
the mobilization of inflammatory cells. First described in
1985,9 uPAR is a glycosyl-phosphatidylinositol -anchored
molecule with high affinity for uPA and pro-uPA. uPAR lacks
a cytosolic domain, but has the ability to transmit intracellular
signals through interaction with several transmembrane
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proteins such as integrins, G-protein-coupled receptors, and
caveolin.10
uPAR is present at the cell surface of a variety of different
cell types, such as monocytes, macrophages, neutrophils,
T cells, endothelial cells, smooth muscle cells, and renal
tubular epithelial cells.11–16 uPAR has the ability to facilitate
cell migration in two manners. On the one hand, it binds
uPA, resulting in the generation of plasmin activity at the cell
surface, which leads to pericellular proteolysis. On the other
hand, uPAR has been implicated in activation and mobiliza-
tion of leukocytes through interaction with b2 integrins, most
notably CD11b/CD18 (Mac-1, CR3).17
Recently, we reported an upregulation of uPAR expression
during UTI.18 Urine and plasma of patients with culture-
proven urosepsis contained high concentrations of uPAR.
Moreover, in the same study, it was shown that urine and
plasma levels of uPAR increase significantly after intravenous
administration of E. coli lipopolysaccharide in healthy
volunteers. Of note, E. coli lipopolysaccharide has been
shown to establish a concurrent upregulation of uPAR and
CD11b expression on granulocytes.19 In order to investigate
the in vivo role of uPAR during UTI, we induced acute
pyelonephritis in uPAR-deficient mice.
RESULTS
uPAR/ mice display higher bacterial load than WT mice
In order to determine the role of uPAR in upper UTI, acute
pyelonephritis was induced in uPAR/ and wild-type
(WT) mice. uPAR/ mice showed a significantly higher
number of E. coli colony-forming units (CFU) in kidney
homogenates than WT mice (Figure 1). At T¼ 24 h and
T¼ 48 h, the mean number of CFU showed a difference of
approximately 102, indicating that uPAR/ mice have a
seriously impaired ability to clear E. coli-caused infections.
uPAR/ mice have higher cytokine and chemokine levels
during pyelonephritis
In order to investigate whether higher numbers of bacteria in
kidneys of uPAR/mice were accompanied by higher levels
of pro-inflammatory cytokines and chemokines, levels of
interleukin-1b (IL-1b), interleukin-6 (IL-6), keratinocyte-
derived chemokine (KC), macrophage inflammatory protein-2
(MIP-2), and tumor necrosis factor-a (TNF-a) were
determined in kidney homogenates by enzyme-linked
immunosorbent assay. At T¼ 24 h, uPAR/ kidneys
displayed significantly higher levels of these cytokines and
chemokines than WT kidneys (Figure 2a). At T¼ 48 h, levels
were not different between both genotypes (not shown). In
order to investigate whether higher amounts of E. coli CFU
were directly associated with higher levels of cytokines and
chemokines, correlations between CFU and cytokine/chemo-
kine levels were calculated in all infected mice. Except for
TNF-a, cytokine and chemokine levels in renal homogenates
were directly proportional to the amount of CFU in the
kidney (Figure 2b and Table 1).
No difference in neutrophil influx in uPAR/ and WT mice
In order to investigate the extent of inflammation, histo-
logical sections of renal tissue were examined. Neutrophil
numbers were counted on anti-Ly6G-stained paraffin sec-
tions. At T¼ 24 h and T¼ 48 h, both mouse genotypes
showed comparable numbers of neutrophils in renal tissue
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Figure 1 | Higher bacterial outgrowth in uPAR/ mice.
At T¼ 24 h and T¼ 48 h after inoculation, uPAR/ mice (’)
show higher numbers of E. coli CFU than WT mice (&); *Po0.05.
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Figure 2 | Renal cytokine and chemokine levels. (a) uPAR/ mice (’) show higher levels of pro-inflammatory cytokines and chemokines in
kidney homogenates, compared with WT mice (&) at day 1 after inoculation. Data expressed as pg/mg protein, mean7s.e.m.; *Po0.05;
**Po0.01; ***Po0.005. (b) Renal cytokine and chemokine levels are directly proportional to the amount of CFU per kidney, except for TNF-a.
Correlation coefficients and P-values are displayed in Table 1.
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(24 h: 7667262 (uPAR/) vs 10247331 (WT); 48 h:
4237138 (uPAR/) vs 3197190 (WT), mean number of
neutrophils per eight high-power fields7s.e.m., P40.05 for
both time points). As shown in Figure 3, both uPAR/ and
WT mice showed massive influx of neutrophils in the pyelum
region. Neutrophils were present in the lamina propria, but
invaded the urothelium as well (Figure 3).
In order to confirm the above-mentioned histological
findings, myeloperoxidase (MPO) measurements on kidney
homogenates were performed by enzyme-linked immuno-
sorbent assay. At both time points, no significant differences
were measured in uPAR/ and WT mice, confirming that
there was no difference in neutrophil influx between these
types of mice (Figure 4a).
uPAR/ neutrophils have lower bactericidal potential than
WT neutrophils
Although uPAR/ mice showed the same numbers of
intra-renal neutrophils, they displayed higher numbers of
E. coli CFU, suggesting that uPAR/ neutrophils might have
an impaired ability to eliminate E. coli. In order to further
investigate this hypothesis, neutrophil potential to generate
an oxidative burst reaction was determined. As shown in
Figure 4b, uPAR/ and WT neutrophils produced a
comparable oxidative burst upon activation with E. coli.
Further, a phagocytosis assay was performed with uPAR/
and WT neutrophils. As shown in Figure 5, uPAR/
neutrophils indeed showed a significantly lower phagocytic
potential than WT neutrophils. After 10 min of incubation,
uPAR/ neutrophils showed no further increase in mean
fluorescence intensity (MFI), representing the number of
ingested green fluorescent protein (GFP)-E. coli orga-
nisms, whereas WT neutrophils continued to phagocytose
GFP-E. coli.
DISCUSSION
In a previous study, we demonstrated upregulation of uPAR
expression during UTIs and urosepsis, indicating a physio-
logical role for uPAR during infections of the urinary tract.18
The present study shows that uPAR/mice have a seriously
impaired bacterial clearance during acute pyelonephritis,
caused by a lower ability to phagocytose E. coli organisms.
The importance of uPAR in the defense against micro-
organisms has been shown by other studies as well. uPAR/
Table 1 | Correlation between amounts of CFU and cytokine
levels
Correlation coefficient P-value
TNF-a 0.48 0.82
IL-1b 0.762 o0.01
IL-6 0.626 o0.01
KC 0.423 o0.05
MIP-2 0.902 o0.01
CFU, colony-forming units; IL-1b, interleukin-1b; IL-6, interleukin-6; KC, keratinocyte-
derived chemokine; MIP-2, macrophage inflammatory protein-2.
Correlation coefficients and P-values of the correlation between the amount of CFU
and cytokine levels within all infected kidneys (plotted in Figure 2b).
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Figure 3 | Histology. Photomicrographs of (a, c) uPAR/ kidneys
and (b, d) WT kidneys. (a, b) Both uPAR/ and WT kidneys show
a dense inflammatory infiltrate and tissue necrosis in the pyelum
region. (c, d) The infiltrate consists chiefly of neutrophils that invade
the lamina propria but also the urothelium (arrows). T¼ 24 h after
inoculation, H&E staining, original magnifications (a, b) 40 and
(c, d) 400.
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Figure 4 | Renal myeloperoxidase levels and oxidative burst of
neutrophils. (a) At T¼ 24 h and T¼ 48 h after inoculation, MPO levels
were not different between uPAR/ (’) and WT (&) mice. Data
expressed as mean7s.e.m.; P¼NS. (b) uPAR/ (’) and WT (&)
neutrophils display a comparable capacity to generate oxidative
burst upon stimulation with E. coli 1677. Data expressed as MFI, mean
MFI7s.e.m.; P¼NS. Data represent n¼ 3.
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Figure 5 | Lower phagocytosis capacity of uPAR/ neutrophils.
uPAR/ neutrophils (’) display a significantly reduced capacity
to ingest GFP-E. coli at T¼ 15 min and 20 min, compared with WT
neutrophils (&). Data expressed as MFI per neutrophil (representing
the number of phagocytosed GFP-E. coli), mean MFI7s.e.m.;
*Po0.05. Data represent n¼ 3.
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mice showed significantly fewer neutrophils in bron-
choalveolar lavage fluid during Pseudomonas aeruginosa-
caused pneumonia, resulting in higher numbers of surviving
bacteria.20 In Streptococcus pneumoniae-induced pneumonia,
comparable results were obtained; uPAR/ mice displayed
more severe disease, with significantly higher numbers of S.
pneumoniae CFU in lung tissue and lower pulmonary influx
of neutrophils.21 Furthermore, a recent study concerning
experimental pneumococcal meningitis showed that uPAR/
mice had significantly attenuated cerebrospinal fluid
pleocytosis 24 h after inoculation, compared with WT mice.22
These studies have demonstrated that uPAR is crucially
involved in neutrophil migration towards the site of
infection. Apart from its ability to concentrate proteolytic
activity on the cell surface, uPAR can facilitate cell migration
in a non-proteolytic fashion through interaction with several
integrins.10 uPAR mediates neutrophil migration predomi-
nantly via interaction with b2 integrin CD11b/CD18.
23,24 Our
finding that uPAR/ mice experience higher bacterial load
than WT mice during acute pyelonephritis seems largely in
accordance with the above-mentioned studies. Opposed to
the pulmonary infection models however, bacterial persis-
tence is not associated with diminished neutrophil influx in
the uPAR/ mice in our model. In view of the well-
described function of uPAR in migration of inflammatory
cells, this is an unexpected finding. Several studies concerning
pyelonephritis have demonstrated that UTI susceptibility
correlates with neutrophil influx. However, this effect seems
to depend strongly on the number of CFU in the inoculum
and the strain of E. coli used. Although Toll-like receptor 4
mutant mice invariably show an impaired neutrophil
recruitment in experimental pyelonephritis, some authors
describe higher amounts of renal E. coli CFU in Toll-like
receptor 4 mutant mice,25 whereas others report no
differences in bacterial load between mutant and non-mutant
mice.7 Furthermore, in a previous study, we demonstrated
that the administration of anti-CXCR2 antibodies in this
model inhibits neutrophil influx nearly completely, but this
resulted in higher bacterial counts in renal tissue only at
T¼ 24 h. At other time points, bacterial load was completely
comparable to control mice.26 Although these studies clearly
demonstrate the important role of neutrophils in host
defense to infection, they also provide evidence for
redundancy and complexity in the mechanism of neutrophil
recruitment, as well as the importance of kinetics in mouse
models of infectious diseases.
In the present study, no differences are found in the
numbers of infiltrating neutrophils in the pyelum region of
uPAR/ and WT mice. In a previous study concerning a
murine model of peritonitis, we demonstrated that uPAR/
mice displayed decreased neutrophil migration into the
peritoneal cavity during lipopolysaccharide-induced perito-
nitis.27 On the other hand, no differences in neutrophil influx
were encountered when peritonitis was induced by intra-
abdominal administration of intact E. coli. Taken together,
these results suggest that the net effect of uPAR on neutrophil
migration not only depends on the involved bacteria or
disease model, but can show organ specificity as well. In
addition, neutrophil apoptosis might play a role. It has been
shown that neutrophils can undergo apoptosis after ingestion
of E. coli,28,29 linking phagocytic activity to neutrophil
survival. The observed lower phagocytic capacity of
uPAR/ neutrophils might thus lead to a higher neutrophil
survival rate, possibly masking a lower migratory potential.
We have attempted to demonstrate this in our study by
counting apoptotic neutrophils on sections stained for active
caspase 3. Although uPAR/ kidneys displayed a trend
towards a lower percentage of apoptotic neutrophils, this
trend did not reach statistical significance (data not shown).
Another explanation for the similar neutrophil influx is that
the relative impairment of migratory potential of uPAR/
neutrophils is overruled by the higher levels of pro-
inflammatory cytokines and chemokines at T¼ 24 h in
uPAR/ kidneys. The difference in cytokine levels was
only noted at T¼ 24 h, whereas neutrophil numbers were
similar at both time points. Possibly, granulocytes that had
infiltrated renal tissue at 24 h after infection remained at 48 h
independent of chemoattraction.
IL-1b, IL-6, KC, MIP-2, and TNF-a have all been
implicated in the inflammatory response during UTI.2 After
inoculation with uropathogenic E. coli, bladder and tubular
epithelial cells have been shown to produce IL-1b, IL-6, IL-8
(murine homolog: MIP-2), and TNF-a.30–32 uPAR/
kidneys showed significantly higher levels of pro-inflamma-
tory cytokines and chemokines compared to WT kidneys,
probably as a direct consequence of the 100-fold increase in E.
coli CFU in uPAR/ animals. Indeed, renal cytokine levels
are directly correlated to the amount of CFU in our model.
The present study shows that uPAR/ neutrophils have a
lower capacity to phagocytose E. coli organisms in vitro. This is
in accordance with an earlier report by Gyetko et al.,33 which
demonstrated that uPAR/ neutrophils show less phagocytosis
of BODIPY-stained E. coli after sonication. Our results show that
uPAR is not only involved in phagocytosis of fragmented
bacteria but of whole E. coli organisms as well; an observation
that not only corroborates the observations of Gyetko et al., but
underlines the clinical relevance of these findings.
In the same article it was shown that uPAR/
neutrophils had a lower potential to generate a respiratory
burst after stimulation with high concentrations of the
bacterial peptide N-formyl-methionyl-leucyl-phenylalanine.
However, after stimulation with phorbol 12-myristate
13-acetate, no differences in oxidative burst could be
measured.33 Another study has shown that uPA enhances
N-formyl-methionyl-leucyl-phenylalanine-induced super-
oxide production by neutrophils through uPAR in a
CD11b/CD18-dependent fashion.34 In contrast to these
studies in which synthetic peptides where used as stimulus,
our study shows no differences in oxidative burst generation
after stimulation of uPAR/ and WT neutrophils with E. coli
1677, a strain that was isolated from a uroseptic patient and has
uropathogenic virulence factors. Apparently, the generation of
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reactive oxygen species can be influenced by uPAR but is
dependent on the applied method.
There is increasing evidence that neutrophils not only
migrate through uPAR–CD11b/CD18 interaction but effect
phagocytosis through the same mechanism as well. Activa-
tion of the uPAR–CD11b/CD18 partnership activates a
signaling cascade, which via tyrosine kinases results in the
activation of type 1 phosphoinositide 3-kinases (PI3Ks).10,35
After subsequent modulation of the cytoskeleton, type 1
PI3K causes cell polarization, leading to actual cell move-
ment.36 A number of studies have shown that activation of
CD11b/CD18 via a similar signaling cascade can be of crucial
importance for phagocytosis. Neutrophils have the ability to
ingest opsonized particles via CD11b/CD18, after which
subsequent induction of type 1 PI3K establishes phagosome
maturation37 and actual phagocytosis.36 Indeed, treatment of
neutrophils with the specific PI3K inhibitor Wortmannin not
only prevented CD11b/CD18-mediated neutrophil adhesion
and mobility38 but resulted in an impairment of phagocytosis
as well.39–41 Although further research will be needed, it
seems likely that the association of uPAR with CD11b/CD18
leads to enhanced phagocytosis and elimination of E. coli via
the PI3K pathway in vivo.
Taken together, the present investigation shows that uPAR
is crucially involved in host defense mechanisms during
E. coli-induced UTIs.
MATERIALS AND METHODS
Mice and experimental protocol
uPAR/ mice on a C57BL/6J background were purchased from
The Jackson Laboratory (Bar Harbor, ME, USA) and bred in the
institutional animal facilities. Age- and weight-matched C57Bl/6
mice (Charles River, Maastricht, The Netherlands) served as WT
control.
UTI was induced as described previously.26 E. coli 1677, isolated
from a uroseptic patient, was donated by Dr WJ Hopkins
(University of Wisconsin Medical School, Madison, WI, USA). This
strain has virulence factors that include type 1 and P fimbriae,
hemolysin, and aerobactin.42 Bacteria were cultured for 16 h at 371C
in trypticase soy broth (TSB). After dilution 1:100 in fresh TSB, the
suspension was grown for 3 h to mid-logarithmic phase. E. coli were
washed three times in sterile PBS. The bacteria were resuspended in
PBS at a concentration of 1 1010 CFU/ml, as determined by
plating 10-fold serial dilutions of the suspension on blood agar
plates. Acute pyelonephritis was induced under general anesthesia
(0.07 ml/10 g mouse of FFM mixture, containing 1.25 mg/ml
midazolam (Roche, Mijdrecht, The Netherlands), 0.08 mg/ml
fentanyl citrate, and 2.5 mg/ml fluanisone (Janssen Pharmaceutica,
Beerse, Belgium)) in 8–10 weeks old female mice. In total, 100ml of
bacterial suspension (1 109 CFU) were administered transureth-
rally through a 0.55 mm catheter (Abbott, Zwolle, The Netherlands).
Sham control mice underwent the same procedure with adminis-
tration of 100ml of sterile PBS instead of bacterial suspension. Mice
(n¼ 8 per group) were killed 24 and 48 h after the procedure by
exsanguination under general anesthesia. The Committee on Use
and Care of Animals of the Academic Medical Center at the
University of Amsterdam approved all experiments. Animal
experimentation guidelines were followed in all experiments.
Determination of bacterial outgrowth
Bacterial load was determined in renal tissue as described earlier.26
One half of the left kidney from each mouse was homogenized in
four volumes of sterile saline with a tissue homogenizer which was
cleaned with 70% ethanol after each homogenization. Serial 10-fold
dilutions were made in sterile saline, and 50 ml volumes of kidney
homogenate were plated onto blood agar plates, which were
incubated at 371C for 16 h, after which E. coli CFU were counted.
Histologic examination
The remaining part of the left kidney was fixed in 10% formalin and
embedded in paraffin. Sections (4 mm) were stained with hematox-
ylin–eosin. For granulocyte immunostaining, slides were pretreated
with 0.25% pepsin (Sigma, St Louis, MO, USA) in 0.01 M HCl.
Endogenous peroxidase activity was quenched by 0.1% NaN3/0.03%
H2O2 and free protein-binding sites were blocked with 10% normal
goat serum. After incubation with fluorescein isothiocyanate
(FITC)-labeled antimouse Ly6G monoclonal antibody (Pharmingen,
Erembodegem, Belgium), slides were incubated with a rabbit-
anti-fluorescein isothiocyanate antibody followed by polymerized
horseradish peroxidase-conjugated goat-anti-rabbit IgG antibody
(Powervision; Immunovision Technology, Daly City, CA, USA).
Bound antibodies were visualized with 3,3-diamino-benzidine
tetrachloride (DAB, Sigma). Neutrophil numbers were counted in
the pyelum in eight non-overlapping high-power fields (original
magnification  400).
Cytokine, chemokine, and MPO measurements
The right kidney of each mouse was homogenated in PBS
containing 1% Triton X-100, 1 mM EDTA (Merck), and 1% protease
inhibitor cocktail (P8340, Sigma). Levels of IL-1b, IL-6, KC, MIP-2,
TNF-a, and mouse MPO in kidney homogenates were measured
by specific enzyme-linked immunosorbent assay according to
the instructions of the manufacturer (MPO: HyCult biotechno-
logies, Uden, The Netherlands; others: R&D systems, Minneapolis,
MN, USA).
Oxidative burst and phagocytosis assay
Oxidative burst of neutrophils was assessed by dihydrorhodamine
123 (Sigma) measurement according to Kampen et al.43 Circulating
cells (50 ml whole blood) were loaded with 1.5 mg/ml dihydro-
rhodamine 123 for 30 min. Neutrophils were stimulated by addition
of 50 106 CFU E.coli 1677/ml for 30 min, followed by red blood
cell lysis. Conversion of dihydrorhodamine was determined by flow
cytometry.
Expression of enhanced green fluorescent protein (eGFP) was
induced in E. coli Top-10 (Invitrogen, Breda, The Netherlands), by
transfection with pBBR1MCS-5-eGFP (clone pMP2463),44 which
was kindly provided by Professor H Spaink (Leiden University,
Leiden, The Netherlands). Bacteria were grown under high selective
pressure (40 mg/ml gentamycin, Sigma). eGFP expression was
confirmed by flow cytometry and fluorescent microscopy (data
not shown). Phagocytosis capacity of WT and uPAR/ neutro-
phils was determined by flow cytometry. In short, GFP-E. coli
(equivalent to 50 103 CFU) was added to 50 ml of heparinized full
blood from WT or uPAR/mice and allowed to incubate for 5, 10,
15, or 20 min, vigorously shaking in a water bath at 371C.
Phagocytosis was stopped by immediately transferring the samples
to ice. Erythrocytes were lysed using a hypotonic lysis buffer and
neutrophils were labeled using anti-Ly6-G-antigen-presenting cells
1946 Kidney International (2006) 70, 1942–1947
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(Pharmingen). Samples were washed with ice-cold fluorescence-
activated cell sorter buffer after which the degree of phagocytosis
was determined using a flow cytometer (FACScalibur, Becton
Dickinson, Franklin Lakes, NJ, USA). Results are expressed as MFI
per neutrophil.
Statistical analysis
Data were analyzed by Mann–Whitney U-test. Correlations were
calculated by Pearson’s product–moment correlation test. Po0.05
was considered to represent a statistically significant difference.
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